A detailed history of Braun Stacey Associates Inc transactions in Danaher Corp stock. As of the latest transaction made, Braun Stacey Associates Inc holds 86,007 shares of DHR stock, worth $19.9 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
86,007
Previous 88,186 2.47%
Holding current value
$19.9 Million
Previous $22 Million 8.51%
% of portfolio
0.94%
Previous 0.76%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$239.25 - $280.76 $521,325 - $611,776
-2,179 Reduced 2.47%
86,007 $23.9 Million
Q2 2024

Jul 29, 2024

SELL
$235.51 - $267.98 $272,485 - $310,052
-1,157 Reduced 1.3%
88,186 $22 Million
Q1 2024

Apr 30, 2024

BUY
$224.58 - $256.19 $6.65 Million - $7.58 Million
29,589 Added 49.52%
89,343 $22.3 Million
Q4 2023

Jan 23, 2024

SELL
$185.1 - $233.13 $319,297 - $402,149
-1,725 Reduced 2.81%
59,754 $13.8 Million
Q3 2023

Nov 21, 2023

SELL
$233.08 - $265.59 $757,510 - $863,167
-3,250 Reduced 5.02%
61,479 $15.3 Million
Q2 2023

Jul 28, 2023

SELL
$224.99 - $256.14 $15.1 Million - $17.1 Million
-66,921 Reduced 50.83%
64,729 $15.5 Million
Q1 2023

May 08, 2023

BUY
$239.75 - $277.0 $17.9 Million - $20.7 Million
74,567 Added 130.63%
131,650 $33.2 Million
Q4 2022

Feb 07, 2023

SELL
$241.42 - $282.29 $2.05 Million - $2.4 Million
-8,493 Reduced 12.95%
57,083 $15.2 Million
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $379,484 - $2.32 Million
1,536 Added 2.4%
65,576 $16.9 Million
Q2 2022

Jul 27, 2022

SELL
$237.11 - $299.66 $3.01 Million - $3.81 Million
-12,714 Reduced 16.56%
64,040 $16.2 Million
Q1 2022

Apr 28, 2022

SELL
$257.27 - $315.76 $942,380 - $1.16 Million
-3,663 Reduced 4.56%
76,754 $22.5 Million
Q4 2021

Jan 25, 2022

SELL
$292.08 - $329.01 $1.4 Million - $1.58 Million
-4,806 Reduced 5.64%
80,417 $26.5 Million
Q3 2021

Dec 01, 2021

SELL
$272.21 - $332.43 $1.36 Million - $1.66 Million
-4,989 Reduced 5.53%
85,223 $25.9 Million
Q2 2021

Jul 23, 2021

SELL
$225.08 - $271.69 $340,546 - $411,066
-1,513 Reduced 1.65%
90,212 $24.2 Million
Q1 2021

Apr 28, 2021

SELL
$212.38 - $245.9 $128,914 - $149,261
-607 Reduced 0.66%
91,725 $20.6 Million
Q4 2020

Feb 03, 2021

SELL
$212.5 - $245.46 $2.79 Million - $3.22 Million
-13,132 Reduced 12.45%
92,332 $20.5 Million
Q3 2020

Oct 27, 2020

SELL
$177.16 - $215.33 $1.05 Million - $1.27 Million
-5,900 Reduced 5.3%
105,464 $22.7 Million
Q2 2020

Aug 06, 2020

BUY
$128.7 - $176.83 $93,564 - $128,555
727 Added 0.66%
111,364 $19.7 Million
Q1 2020

Jun 09, 2020

SELL
$121.39 - $169.05 $1.69 Million - $2.36 Million
-13,956 Reduced 11.2%
110,637 $15.3 Million
Q4 2019

Jan 24, 2020

SELL
$133.47 - $153.48 $1.97 Million - $2.26 Million
-14,733 Reduced 10.57%
124,593 $19.1 Million
Q3 2019

Oct 31, 2019

BUY
$135.4 - $146.47 $459,953 - $497,558
3,397 Added 2.5%
139,326 $20.1 Million
Q2 2019

Jul 25, 2019

SELL
$124.88 - $143.73 $195,312 - $224,793
-1,564 Reduced 1.14%
135,929 $19.4 Million
Q1 2019

Apr 25, 2019

BUY
$97.62 - $132.29 $330,443 - $447,801
3,385 Added 2.52%
137,493 $18.2 Million
Q4 2018

Jan 28, 2019

BUY
$94.85 - $109.54 $31,774 - $36,695
335 Added 0.25%
134,108 $13.8 Million
Q3 2018

Oct 29, 2018

SELL
$98.13 - $108.9 $17,172 - $19,057
-175 Reduced 0.13%
133,773 $14.5 Million
Q2 2018

Aug 01, 2018

SELL
$96.1 - $103.24 $67,270 - $72,268
-700 Reduced 0.52%
133,948 $13.2 Million
Q1 2018

May 01, 2018

BUY
$92.16 - $103.8 $297,216 - $334,755
3,225 Added 2.45%
134,648 $13.2 Million
Q4 2017

Jan 30, 2018

BUY
$85.26 - $94.62 $517,954 - $574,816
6,075 Added 4.85%
131,423 $12.2 Million
Q3 2017

Oct 25, 2017

BUY
$79.29 - $88.45 $9.94 Million - $11.1 Million
125,348
125,348 $10.8 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Braun Stacey Associates Inc Portfolio

Follow Braun Stacey Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.